台灣臨床試驗主持人資料庫|TPIDB

問卷

Log In

繁中 EN

TPIDB

TPIDB Outstanding PI

TPIDB > Study Site > 收納受試者人數排名

Search Result

List

113Cases

2017-01-01 - 2020-06-30

Phase III

A Phase 3 Multicenter, Randomized, Double-blind,Placebo-controlled Study with an Open Label Extension to Evaluatethe Efficacy and Safety of KHK4827 in Subjects with Axial Spondyloarthritis

Condition/Disease

Axial Spondyloarthritis
Test Drug

KHK4827 (Brodalumab)

Participate Sites
13Sites

Terminated11Sites

羅淑芬

Linkou Chang Gung Medical Foundation

黃春明

China Medical University Hospital-Taipei

未分科

2016-02-01 - 2020-06-30

Phase III

Condition/Disease
Test Drug

Participate Sites
2Sites

Terminated2Sites

張文震

Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

2015-11-01 - 2020-02-17

Phase III

A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC in Combination with Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults with Early Rheumatoid Arthritis who are Methotrexate Naive

Condition/Disease

Rheumatoid Arthritis
Test Drug

Abatacept

Participate Sites
4Sites

Terminated4Sites

郭昶甫

Linkou Chang Gung Medical Foundation

Division of Rheumatology

1 Previous page 8 9 10 11 12